JPO2/CDCA7L and LEDGF/p75 Are Novel Mediators of PI3K/AKT Signaling and Aggressive Phenotypes in Medulloblastoma - Chan, T S; Hawkins, C; Krieger, J R (Cancer Res, 2016)
et al.